Barrow B - Search Results

1

Clinical characteristics of subjects with a missense mutation in glucokinase.

Page RC, Hattersley AT, Levy JC, Barrow B, Patel P, Lo D, Wainscoat JS, Permutt MA, Bell GI, Turner RC. Page RC, et al. Among authors: barrow b. Diabet Med. 1995 Mar;12(3):209-17. doi: 10.1111/j.1464-5491.1995.tb00460.x. Diabet Med. 1995. PMID: 7758256

2

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.

McLellan JA, Barrow BA, Levy JC, Hammersley MS, Hattersley AT, Gillmer MD, Turner RC. McLellan JA, et al. Among authors: barrow ba. Diabetologia. 1995 Jun;38(6):693-8. doi: 10.1007/BF00401841. Diabetologia. 1995. PMID: 7672491

3

Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees.

Cook JT, Hattersley AT, Christopher P, Bown E, Barrow B, Patel P, Shaw JA, Cookson WO, Permutt MA, Turner RC. Cook JT, et al. Among authors: barrow b. Diabetes. 1992 Nov;41(11):1496-500. doi: 10.2337/diab.41.11.1496. Diabetes. 1992. PMID: 1397724

4

High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population.

Saker PJ, Hattersley AT, Barrow B, Hammersley MS, McLellan JA, Lo YM, Olds RJ, Gillmer MD, Holman RR, Turner RC. Saker PJ, et al. Among authors: barrow b. Diabetologia. 1996 Nov;39(11):1325-8. doi: 10.1007/s001250050577. Diabetologia. 1996. PMID: 8932999

5

UKPDS 21: low prevalence of the mitochondrial transfer RNA gene (tRNA(Leu(UUR))) mutation at position 3243bp in UK Caucasian type 2 diabetic patients.

Saker PJ, Hattersley AT, Barrow B, Hammersley MS, Horton V, Gillmer MD, Turner RC. Saker PJ, et al. Among authors: barrow b. Diabet Med. 1997 Jan;14(1):42-5. doi: 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T. Diabet Med. 1997. PMID: 9017352

6

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.

Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC. Rachman J, et al. Among authors: barrow ba. Diabetes. 1996 Nov;45(11):1524-30. doi: 10.2337/diab.45.11.1524. Diabetes. 1996. PMID: 8866556

7

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.

Rachman J, Barrow BA, Levy JC, Turner RC. Rachman J, et al. Among authors: barrow ba. Diabetologia. 1997 Feb;40(2):205-11. doi: 10.1007/s001250050664. Diabetologia. 1997. PMID: 9049482 Clinical Trial.

8

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.

Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC. Rachman J, et al. Among authors: barrow ba. Diabetes. 1997 Oct;46(10):1557-62. doi: 10.2337/diacare.46.10.1557. Diabetes. 1997. PMID: 9313749 Clinical Trial.

9

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC. Rachman J, et al. Among authors: barrow ba. Diabetes Care. 1998 May;21(5):810-6. doi: 10.2337/diacare.21.5.810. Diabetes Care. 1998. PMID: 9589246 Clinical Trial.

10

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.

MacNamara CM, Barrow BA, Manley SE, Levy JC, Clark A, Turner RC. MacNamara CM, et al. Among authors: barrow ba. Diabetes Res Clin Pract. 2000 Oct;50(2):117-26. doi: 10.1016/s0168-8227(00)00188-1. Diabetes Res Clin Pract. 2000. PMID: 10960722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters